K
Koen Augustyns
Researcher at University of Antwerp
Publications - 227
Citations - 6882
Koen Augustyns is an academic researcher from University of Antwerp. The author has contributed to research in topics: Dipeptidyl peptidase & Proteases. The author has an hindex of 43, co-authored 214 publications receiving 5849 citations. Previous affiliations of Koen Augustyns include Rega Institute for Medical Research & Fox Chase Cancer Center.
Papers
More filters
Journal ArticleDOI
Kinetic Investigation of Chemokine Truncation by CD26/Dipeptidyl Peptidase IV Reveals a Striking Selectivity within the Chemokine Family
Anne-Marie Lambeir,Paul Proost,Christine Durinx,Gunther Bal,Kristel Senten,Koen Augustyns,Simon Scharpé,Jo Van Damme,Ingrid De Meester +8 more
TL;DR: The steady-state catalytic parameters for a relevant selection of chemokines previously reported to alter their chemotactic behavior due to CD26/dipeptidyl peptidase IV-catalyzed truncation are determined and reveal a striking selectivity for stromal cell-derived factor-1α (CXCL12) and macrophage-derived chemokine (CCL22).
Journal ArticleDOI
Truncation of Macrophage-derived Chemokine by CD26/ Dipeptidyl-Peptidase IV beyond Its Predicted Cleavage Site Affects Chemotactic Activity and CC Chemokine Receptor 4 Interaction
Paul Proost,Sofie Struyf,Dominique Schols,Ghislain Opdenakker,Silvano Sozzani,Paola Allavena,Alberto Mantovani,Koen Augustyns,Gunther Bal,Achiel Haemers,Anne-Marie Lambeir,Simon Scharpé,Jo Van Damme,Ingrid De Meester +13 more
TL;DR: NH2-terminal truncation of MDC by CD26/DPP IV has profound biological consequences and may be an important regulatory mechanism during the migration of Th2 lymphocytes and dendritic cells to germinal centers and to sites of inflammation.
Journal ArticleDOI
Extended Structure–Activity Relationship and Pharmacokinetic Investigation of (4-Quinolinoyl)glycyl-2-cyanopyrrolidine Inhibitors of Fibroblast Activation Protein (FAP)
Koen Jansen,Leen Heirbaut,Robert Verkerk,Jonathan D. Cheng,Jurgen Joossens,Paul Cos,Louis Maes,Anne-Marie Lambeir,Ingrid De Meester,Koen Augustyns,Pieter Van der Veken +10 more
TL;DR: In this paper, the authors explored the structure-activity relationship around the core scaffold of the N-4-quinolinoyl-gly-(2S)-cyanoPro scaffold and reported extensively optimized compounds that display low nanomolar inhibitory potency and high selectivity against the related dipeptidyl peptidases (DPPs) DPPIV, DPP9, and prolyl oligopeptidase (PREP).
Journal ArticleDOI
In vitro antioxidant profile of phenolic acid derivatives.
Paul Cos,Padinchare Rajan,Irina Vedernikova,M. Calomme,Luc Pieters,Arnold J. Vlietinck,Koen Augustyns,Achiel Haemers,Dirk Vanden Berghe +8 more
TL;DR: Several caffeic acid esters isolated from propolis exhibit interesting antioxidant properties, but their in vivo use is compromised by hydrolysis of the ester bond in the gastrointestinal tract, so their in vitro antioxidant profile was determined.
Journal ArticleDOI
When PERK inhibitors turn out to be new potent RIPK1 inhibitors: critical issues on the specificity and use of GSK2606414 and GSK2656157.
Diego Rojas-Rivera,Tinneke Delvaeye,Ria Roelandt,Wim Nerinckx,Koen Augustyns,Peter Vandenabeele,Mathieu J.M. Bertrand +6 more
TL;DR: These results not only report on new and very potent RIPK1 inhibitors but also highlight the risk of misinterpretation when using these two PERK inhibitors in the context of ER stress, cell death and inflammation.